Obesity Study Guide

📖 Core Concepts Obesity: Excess body fat that harms health; clinically defined by BMI ≥ 30 kg/m². BMI (Body‑Mass Index): $$\text{BMI} = \frac{\text{weight (kg)}}{\text{height (m)}^{2}}$$ – quick screening tool but does not distinguish fat from muscle. Set‑point Theory: The body defends a “preferred” weight; after weight gain the set point can reset higher, making loss difficult. Leptin vs. Ghrelin: Leptin (from fat) signals satiety; resistance → overeating. Ghrelin (from stomach) signals hunger; high levels → increased intake. Metabolically Healthy Obesity (MHO): Obese BMI but normal insulin, lipids, BP; definition varies. Survival Paradox: In some chronic‑disease groups (e.g., heart failure) BMI 30‑34.9 kg/m² is linked to lower mortality than normal weight. --- 📌 Must Remember BMI thresholds: Overweight: 25–29.9 kg/m² Obesity class 1: 30–34.9 kg/m² Class 2: 35–39.9 kg/m² Class 3 (morbid): ≥ 40 kg/m² (≥ 45 kg/m² in some defs) Asian cut‑offs: Overweight ≥ 23 kg/m², Obesity ≥ 25 kg/m². Waist‑circumference risk: > 102 cm (men) / > 88 cm (women). Mortality impact: Obesity ≈ 6–7 yr reduced life expectancy; 2.8 M deaths/year (WHO, 2021). Cardiometabolic risk: Each 5‑unit BMI increase ≈ 2× risk of type 2 diabetes. Key meds causing weight gain: insulin, sulfonylureas, thiazolidinediones, atypical antipsychotics, systemic steroids, some anticonvulsants, hormonal contraceptives. Approved long‑term drugs: liraglutide, semaglutide, tirzepatide, naltrexone/bupropion, orlistat, phentermine/topiramate. Bariatric surgery criteria: BMI ≥ 40 kg/m², or ≥ 35 kg/m² with serious comorbidities. --- 🔄 Key Processes Positive Energy Balance → Weight Gain Energy intake > energy expenditure → fat storage. Chronic surplus can shift the hypothalamic set‑point upward. Leptin Regulation Loop ↑ adipose → ↑ leptin → hypothalamic POMC/CART activation → satiety. Leptin resistance blunts this feedback → continued eating. Melanocortin Pathway NPY/AgRP neurons → stimulate lateral hypothalamus (hunger). POMC/CART neurons → stimulate ventromedial hypothalamus (satiety). Leptin ↓ NPY/AgRP, ↑ POMC/CART. Weight‑loss Maintenance Cycle ↓ calories → weight loss → ↓ leptin → increased hunger & reduced EE → set‑point defense → high relapse risk. --- 🔍 Key Comparisons BMI vs. Waist Circumference – BMI gauges overall adiposity; waist circumference captures central (visceral) fat, a stronger predictor of CVD. Leptin Resistance vs. Ghrelin Excess – Leptin resistance = impaired satiety despite high fat mass; ghrelin excess = heightened hunger regardless of adiposity. Lifestyle‑only vs. Pharmacologic‑plus‑Lifestyle – Diet/exercise alone yields modest, often transient loss; adding GLP‑1 agonists or bariatric surgery amplifies magnitude and durability. Class 1 Obesity vs. Metabolically Healthy Obesity – Same BMI, but MHO lacks insulin resistance, dyslipidemia, hypertension. --- ⚠️ Common Misunderstandings “BMI is a perfect measure” – It misclassifies muscular people and ignores fat distribution. “All obese people are metabolically unhealthy” – Up to 30 % may meet MHO criteria. “Low‑fat diets are always best” – Evidence shows low‑carb and low‑fat produce similar long‑term weight loss; adherence matters more. “Bariatric surgery is only for cosmetic purposes” – It is the most effective therapy for severe obesity and reduces mortality. --- 🧠 Mental Models / Intuition Energy‑Balance Equation: Weight change = (Calories In) – (Calories Out); think of a bank account – deposits (food) must be less than withdrawals (activity) to “save” weight loss. Set‑Point as Thermostat: The hypothalamus tries to keep body weight at the “set temperature.” Raising the thermostat (weight gain) makes the body defend that higher level. Leptin–Ghrelin Tug‑of‑War: Picture two ropes pulling on appetite—leptin pulls toward satiety, ghrelin pulls toward hunger. Resistance or excess tips the balance toward overeating. --- 🚩 Exceptions & Edge Cases Survival Paradox: In hemodialysis, heart‑failure, or peripheral artery disease, BMI 30‑34.9 kg/m² may be protective. Asian BMI Cut‑offs: Lower thresholds reflect higher body‑fat percentage at given BMI. Pregnancy: Pre‑conception obesity raises risk of gestational diabetes, pre‑eclampsia, and adverse neonatal outcomes. Children: Obesity defined by > 95th percentile for age/sex, not by absolute BMI value. --- 📍 When to Use Which Screening: Use BMI for quick population‑level triage; add waist circumference if BMI ≥ 30 or in Asian patients. Choosing Pharmacotherapy: Prefer GLP‑1 agonists (semaglutide, liraglutide) when strong appetite suppression needed and cardiovascular benefit is desired. Use orlistat if malabsorption of fat is acceptable and cost is a concern. Surgical Referral: BMI ≥ 40 kg/m² or ≥ 35 kg/m² with uncontrolled diabetes, hypertension, or sleep apnea. Behavioral Intervention: First‑line for all patients; tailor diet (low‑calorie vs. low‑carb) to personal preference and adherence likelihood. --- 👀 Patterns to Recognize “Sweet‑drink + Sedentary” → rapid BMI rise (150 kcal/day from SSBs). Family History + Early‑onset Obesity → possible monogenic (leptin, ob) or strong polygenic (FTO) contribution. Medication List + Weight Gain → suspect insulin, antipsychotics, steroids, etc. Elevated BMI + Normal Labs → consider Metabolically Healthy Obesity; still monitor long‑term risk. --- 🗂️ Exam Traps BMI = 30 kg/m² vs. “Severe obesity” – Severe obesity is defined as BMI ≥ 35 kg/m², not just ≥ 30. Asian vs. General BMI cut‑offs – Forgetting the lower thresholds (23/25) leads to under‑diagnosis in Asian patients. Waist circumference thresholds – Remember gender‑specific cut‑offs (102 cm men, 88 cm women). Medication‑induced weight gain – Many exam stems list “beta‑blockers” but they are not a major weight‑gain culprit; focus on insulin, atypical antipsychotics, steroids. Survival paradox – Choosing “higher BMI always worse” for all patient groups ignores the paradox in heart failure/hemodialysis. ---